Louisville, KY, United States of America

Marco Cecchi

This inventor holds 2 USPTO granted patents. Top assignee: Anavex Life Sciences Corp.. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marco Cecchi. Retrieved from https://idiyas.com/inventor/marco-cecchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marco Cecchi: Innovator in Alzheimer's Disease Treatment

Introduction

Marco Cecchi is a notable inventor based in Louisville, KY, who has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. With a total of two patents to his name, Cecchi's work focuses on innovative pharmaceutical compositions that aim to improve the lives of those affected by this debilitating condition.

Latest Patents

Cecchi's latest patents include a composition and method for the treatment of Alzheimer's disease that incorporates ANAVEX2-73. This method utilizes an intermittent dosage regimen to enhance the effectiveness of the treatment. Additionally, he has developed a crystalline form of ANAVEX2-73, which also targets Alzheimer's disease through similar pharmaceutical compositions and dosage methods.

Career Highlights

Marco Cecchi is associated with Anavex Life Sciences Corp., a company dedicated to advancing treatments for neurodegenerative diseases. His work at Anavex has positioned him as a key player in the ongoing research and development of therapies aimed at combating Alzheimer's disease.

Collaborations

[Section skipped due to space constraints.]

Conclusion

Marco Cecchi's innovative contributions to Alzheimer's disease treatment through his patents and work at Anavex Life Sciences Corp. highlight his commitment to improving patient outcomes in the field of neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…